Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Summary: Background: Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system improved glucose control compared with sensor-assisted...

Full description

Bibliographic Details
Main Authors: Pierre-Yves Benhamou, ProfMD, Sylvia Franc, MD, Yves Reznik, ProfMD, Charles Thivolet, ProfMD, Pauline Schaepelynck, MD, Eric Renard, ProfMD, Bruno Guerci, ProfMD, Lucy Chaillous, MD, Celine Lukas-Croisier, MD, Nathalie Jeandidier, ProfMD, Helene Hanaire, ProfMD, Sophie Borot, MD, Maeva Doron, Pierre Jallon, Ilham Xhaard, PhD, Vincent Melki, MD, Laurent Meyer, MD, Brigitte Delemer, ProfMD, Marie Guillouche, MD, Laurene Schoumacker-Ley, MD, Anne Farret, MD, Denis Raccah, ProfMD, Sandrine Lablanche, MD, Michael Joubert, ProfMD, Alfred Penfornis, ProfMD, Guillaume Charpentier, MD
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:The Lancet: Digital Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2589750019300032

Internet

http://www.sciencedirect.com/science/article/pii/S2589750019300032

Similar Items